SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,718,000 | +6.4% | 17,620 | +1.3% | 0.01% | +20.0% |
| Q4 2014 | $1,614,000 | +37.9% | 17,390 | +2.2% | 0.01% | +25.0% |
| Q3 2014 | $1,170,000 | -33.1% | 17,009 | +1.9% | 0.00% | -33.3% |
| Q2 2014 | $1,750,000 | +59.5% | 16,699 | +26.3% | 0.01% | +50.0% |
| Q1 2014 | $1,097,000 | +50.5% | 13,218 | +17.4% | 0.00% | +100.0% |
| Q4 2013 | $729,000 | +2.2% | 11,258 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $713,000 | +50.7% | 11,258 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $473,000 | – | 11,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |